Diabetogenic T cells induce autoimmune diabetes in BALB/c mice

Chinese Medical Sciences Journal

Volumn 23, Issue 2, 2008, Pages 88-94

  Zou, Xiao Lei ^a   Zhao, Zeng Yu ^a   Wan, Yun Yang ^a   Su, Zhi Qiang ^a   Xiang, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adoptive transfer; Diabetogenic T cells; Streptozotocin induced diabetes mellitus

Indexed keywords

EOSIN; GAMMA INTERFERON; HEMATOXYLIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; CELL CULTURE; CELL FUNCTION; CELL TRANSFER; CONTROLLED STUDY; DIABETOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PANCREAS ISLET; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE;

EID: 47349100995     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60018-3     Document Type: Article

References (23)

1. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994; 15:516-42.
2. Vukkadapu SS, Belli JM, Ishii K, et al. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol Genomics 2005; 21:201-11.
3. Harada M, Makino S. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody. Jikken Dobutsu 1986; 35:501-4.
4. Bisikirska BC, Herold KC. Use of anti-CD3 monoclonal antibody to induce immune regulation in type 1 diabetes. Ann N Y Acad Sci 2004; 1037:1-9.
5. Makhlouf L, Grey ST, Dong V, et al. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nono-bese diabetic mice. Transplantation 2004; 77:990-7.
6. + cells negates the effect. Blood 2005; 105:2577-84.
7. Sempé P, Bédossa P, Richard MF, et al. Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol 1991; 21:1163-9.
8. Bacelj A, Charlton B, Mandel TE. Prevention of cyclophospha-mide-induced diabetes by anti-V beta 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes 1989; 38:1492-5.
9. Füchtenbusch M, Larger E, Thebault K, et al. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content. Horm Metab Res 2005; 37:63-7.
10. Lundsgaard D, Markholst H. A co-transfer system in young prediabetic BB rats: reactivated autoreactive T cells can be partly controlled. J Autoimmun 2003; 21:325-38.
11. Yagi H, Suzuki S, Matsumoto M, et al. Immune deficiency of the CTS mouse. L Deficiency of in vitro T cell-mediated immune response. Immunol Invest 1990; 19:279-95.
12. Lv QJ. Methodology of new drug research in pharmacology. Beijing: Chemical Industry Press; 2007. p. 302.
13. Zhang CL, Zou XL, Peng JB, et al. Immune tolerance induced by adoptive transfer of dendritic cells in an insulin-dependent diabetes mellitus murine model. Acta Pharmacol Sin 2007; 28:98-104.
14. Serreze DV, Leiter EH, Christianson GJ, et al. Major histo-compatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant Diabetes 1994; 43:505-9.
15. Daniel D, Gill RG, Schloot N, et al. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clone isolated from NOD mice. Eur J Immunol 1995; 25:1056-62.
16. + T-cells in the BB/Wor rat Diabetes 1999; 48:975-82.
17. + T-cell-induced diabetes, macrophages are the final effector cells that mediate islet β-cell killing: studies from an acute model. Am J Pathol 2006; 169:2137-47.
18. Karges W, Rajasalu T, Spyrantis A, et al. The diabetogenic, insulin-specific CD8 T cell response primed in the experimental autoimmune diabetes model in RTP-B7. 1 mice. Eur J Immunol 2007; 37:2097-103.
19. Pinkse GG, Tysma OH, Bergen CA, et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 2005; 102:18425-30.
20. Herold KC, Bloch TN, Vezys V, et al. Diabetes induced with low doses of streptozotocin is mediated by Vβ8. 2 + T-cells. Diabetes 1995; 44:354-9.
21. Hayashi T, Morimoto M, Iwata H, et al. Interferon-gamma plays a role in pancreatic islet-cell destruction of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice. Int J Exp Pathol 1998; 79:313-20.
22. Cain JA, Smith JA, Ondr JK, et al. NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol 2006; 176:1645-54.
23. Müller A, Schott-Ohly P, Dohle C, et al. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 2002; 205:35-50.